Comprehensive Genomic Evaluation of Osteosarcoma with a Targeted Next Generation Sequencing Assay Reveals Frequent Actionable Genomic Abnormalities and Potential New Routes to Targeted Therapies
Publication
, Conference
Niu, GG; Al-Rohil, RN; Vanushkina, M; Sheehan, CE; Nazeer, T; DiCaprio, M; Palmer, G; Ali, SM; Morosini, D; Miller, VA; Stephens, PJ; Ross, JS
Published in: LABORATORY INVESTIGATION
February 1, 2014
Duke Scholars
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
February 1, 2014
Volume
94
Start / End Page
23A / 24A
Location
San Diego, CA
Publisher
NATURE PUBLISHING GROUP
Conference Name
103rd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Niu, G. G., Al-Rohil, R. N., Vanushkina, M., Sheehan, C. E., Nazeer, T., DiCaprio, M., … Ross, J. S. (2014). Comprehensive Genomic Evaluation of Osteosarcoma with a Targeted Next Generation Sequencing Assay Reveals Frequent Actionable Genomic Abnormalities and Potential New Routes to Targeted Therapies. In LABORATORY INVESTIGATION (Vol. 94, pp. 23A-24A). San Diego, CA: NATURE PUBLISHING GROUP.
Niu, G. G., R. N. Al-Rohil, M. Vanushkina, C. E. Sheehan, T. Nazeer, M. DiCaprio, G. Palmer, et al. “Comprehensive Genomic Evaluation of Osteosarcoma with a Targeted Next Generation Sequencing Assay Reveals Frequent Actionable Genomic Abnormalities and Potential New Routes to Targeted Therapies.” In LABORATORY INVESTIGATION, 94:23A-24A. NATURE PUBLISHING GROUP, 2014.
Niu GG, Al-Rohil RN, Vanushkina M, Sheehan CE, Nazeer T, DiCaprio M, et al. Comprehensive Genomic Evaluation of Osteosarcoma with a Targeted Next Generation Sequencing Assay Reveals Frequent Actionable Genomic Abnormalities and Potential New Routes to Targeted Therapies. In: LABORATORY INVESTIGATION. NATURE PUBLISHING GROUP; 2014. p. 23A-24A.
Niu, G. G., et al. “Comprehensive Genomic Evaluation of Osteosarcoma with a Targeted Next Generation Sequencing Assay Reveals Frequent Actionable Genomic Abnormalities and Potential New Routes to Targeted Therapies.” LABORATORY INVESTIGATION, vol. 94, NATURE PUBLISHING GROUP, 2014, pp. 23A-24A.
Niu GG, Al-Rohil RN, Vanushkina M, Sheehan CE, Nazeer T, DiCaprio M, Palmer G, Ali SM, Morosini D, Miller VA, Stephens PJ, Ross JS. Comprehensive Genomic Evaluation of Osteosarcoma with a Targeted Next Generation Sequencing Assay Reveals Frequent Actionable Genomic Abnormalities and Potential New Routes to Targeted Therapies. LABORATORY INVESTIGATION. NATURE PUBLISHING GROUP; 2014. p. 23A-24A.
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
February 1, 2014
Volume
94
Start / End Page
23A / 24A
Location
San Diego, CA
Publisher
NATURE PUBLISHING GROUP
Conference Name
103rd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences